Page last updated: 2024-11-02

pentoxifylline and Immunologic Deficiency Syndromes

pentoxifylline has been researched along with Immunologic Deficiency Syndromes in 1 studies

Immunologic Deficiency Syndromes: Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.

Research Excerpts

ExcerptRelevanceReference
"Pentoxifylline was able to ameliorate this nephrotoxic condition as suggested by the change in levels of membrane bound ATPases, MDA and GSH."1.40Carboplatin-induced Fanconi-like syndrome in rats: amelioration by pentoxifylline. ( Bhamre, P; Gandhi, H; Khakhariya, R; Rajput, SJ; Rathod, SP; Trivedi, J; Variya, B, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khakhariya, R1
Rathod, SP1
Gandhi, H1
Variya, B1
Trivedi, J1
Bhamre, P1
Rajput, SJ1

Other Studies

1 other study available for pentoxifylline and Immunologic Deficiency Syndromes

ArticleYear
Carboplatin-induced Fanconi-like syndrome in rats: amelioration by pentoxifylline.
    Environmental toxicology and pharmacology, 2014, Volume: 37, Issue:1

    Topics: Adenosine Triphosphatases; Animals; Antineoplastic Agents; Blood Urea Nitrogen; Carboplatin; Creatin

2014